296
Novo Holdings has agreed to acquire a majority stake in Single Use Support, a life science tools company providing advanced technology solutions for the pharmaceutical production process.
The Denmark-based holding and investment company responsible for managing the assets and the wealth of the Novo Nordisk Foundation will acquire a controlling stake of about 60% in Single Use Support alongside the two company founders, who each retain 10%, and US-based life science company Danaher which keeps 20% of the share capital.
Founded in…